Status:
NOT_YET_RECRUITING
OMERACT SLE Delphi
Lead Sponsor:
University Health Network, Toronto
Collaborating Sponsors:
OMERACT
Conditions:
SLE - Systemic Lupus Erythematosus
Eligibility:
All Genders
18+ years
Brief Summary
SLE is a chronic multi-systemic autoimmune disease with clinical manifestations characterized by recurrent flares in disease activity and damage in several organs. SLE affects primarily women during c...
Detailed Description
Objective Research question • What domains (outcome measurements) of SLE are important to the various SLE stakeholders? Objective • The investigators are attempting to ascertain preliminary opinions...
Eligibility Criteria
Inclusion
- Males and Females
- 18 and older
- Able to read and understand English, Spanish, French, Italian, Portuguese, Japanese, Arabic, Korean, Hebrew, German, and Chinese
- Have access to email and the internet
Exclusion
- Not able to read and understand English, Spanish, French, Italian, Portuguese, Japanese, Arabic, Korean, Hebrew, German, and Chinese
- Does not have access to email and the internet
Key Trial Info
Start Date :
September 15 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 31 2025
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT07136090
Start Date
September 15 2025
End Date
October 31 2025
Last Update
August 22 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.